cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aldeyra Therapeutics Inc
12 own
16 watching
Current Price
$3.97
$0.1
(2.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
205.88M
52-Week High
52-Week High
11.97000
52-Week Low
52-Week Low
1.42000
Average Volume
Average Volume
0.63M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization205.88M
icon52-Week High11.97000
icon52-Week Low1.42000
iconAverage Volume0.63M
iconDividend Yield--
iconP/E Ratio--
What does the Aldeyra Therapeutics Inc do?
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company s lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Read More
How much money does Aldeyra Therapeutics Inc make?
News & Events about Aldeyra Therapeutics Inc.
Globe Newswire
9 months ago
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ( Aldeyra or the Company ) (NASDAQ: ALDX). Such investors...
Globe Newswire
9 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (Aldeyra or the Company) (NASDAQ:ALDX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
9 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc. - ALDX PR Newswire NEW YORK, June 23, 2023 NEW YORK, June 23, 2023...
Business Wire
10 months ago
(Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced that it will be added to the Russell 2000 and the Russell 3000 indexes, effective after the U.S. equity markets close on June 23...
Business Wire
10 months ago
(Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application...
Frequently Asked Questions
Frequently Asked Questions
What is Aldeyra Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Aldeyra Therapeutics Inc shares?
plus_minus_icon
How can I buy Aldeyra Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Aldeyra Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aldeyra Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Aldeyra Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Aldeyra Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aldeyra Therapeutics Inc?
plus_minus_icon
What percentage is Aldeyra Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aldeyra Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.97
$0.1
(2.58%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00